Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

ASP Isotopes Inc. (ASPI) Guidance & Earnings Results

On 2026-08-04 ASP Isotopes Inc. raised guidance: "PET Labs FY2026 revenue guidance raised to ~$14M from $6M in FY2025; helium revenue guidance ~$27M annualized; 2031 EBITDA target >$300M…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

ASPIASP Isotopes Inc.Follow ASPI — free
Chemicals · Basic Materials
—
Price chart with a free account
Market cap
298.2M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
17 Nov, in 24 days

What management guided

each earnings 8-K · figures checked against the filing text
ReleaseDirectionWhat they said
4 Aug 26RaisedPET Labs FY2026 revenue guidance raised to ~$14M from $6M in FY2025; helium revenue guidance ~$27M annualized; 2031 EBITDA target >$300M reaffirmed

ASP Isotopes Inc. — questions

What guidance did ASP Isotopes Inc. give?
On 2026-08-04: "PET Labs FY2026 revenue guidance raised to ~$14M from $6M in FY2025; helium revenue guidance ~$27M annualized; 2031 EBITDA target >$300M reaffirmed"
When does ASP Isotopes Inc. report earnings?
ASP Isotopes Inc.'s next earnings report is expected on 2026-11-17.

Every figure on this page comes from ASP Isotopes Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.